APA (7th ed.) Citation

F, S., H, W., D, Z., N, S., S, C., T, L., . . . S, Y. (2026). Low-dose belimumab reduced risk of flares in patients with systemic lupus erythematosus: A multicentre, randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases, 85(3), 489. https://doi.org/10.1016/j.ard.2025.10.010

Chicago Style (17th ed.) Citation

F, Sun, Wang H, Zhang D, Shen N, Chen S, Li T, Wan W, Dai SM, and Ye S. "Low-dose Belimumab Reduced Risk of Flares in Patients with Systemic Lupus Erythematosus: A Multicentre, Randomised, Double-blind, Placebo-controlled Trial." Annals of the Rheumatic Diseases 85, no. 3 (2026): 489. https://doi.org/10.1016/j.ard.2025.10.010.

MLA (9th ed.) Citation

F, Sun, et al. "Low-dose Belimumab Reduced Risk of Flares in Patients with Systemic Lupus Erythematosus: A Multicentre, Randomised, Double-blind, Placebo-controlled Trial." Annals of the Rheumatic Diseases, vol. 85, no. 3, 2026, p. 489, https://doi.org/10.1016/j.ard.2025.10.010.